8 December 2023 - Little Jack Roche was five weeks old when diagnosed with cystic fibrosis. The medication that could help ...
7 December 2023 - EnGeneIC has achieved a significant milestone with the granting of FDA fast track designation for its ...
8 December 2023 - The Biden Administration on Thursday announced it is setting new policy that will allow it to ...
5 December 2023 - CVS Health is promising to simplify how its pharmacies get paid for drugs. But that doesn’t ...
8 December 2023 - Approval based on results of two paediatric studies in children aged 1 to 17. ...
6 December 2023 - July 19, 2024 PDUFA target action date assigned by the FDA. ...
8 December 2023 - Conditional marketing authorisation is based on clinically meaningful response rates, duration of response, and safety from the ...
7 December 2023 - Avzivi is the second biosimilar researched, developed, and manufactured by a Chinese pharmaceutical company to receive FDA ...
7 December 2023 - Alpha Cognition is pleased to announce that the US FDA has completed its filing review and has ...
7 December 2023 - Formycon, Polpharma Biologics, Bioeq and Teva Canada jointly announce that Health Canada has granted the Notice ...
7 December 2023 - Verzenio's label expanded to include the full study population investigated in the Verzenio Phase 3 monarchE trial. ...
7 December 2023 - New drug application granted priority review with PDUFA date set for 10 June 2024. ...
7 December 2023 - In 1997, Celgene obtained a key patent for what would become a blockbuster blood cancer treatment, ...
7 December 2023 - The Biden administration proposed a rule Thursday that could let the Government seize patents for medicines developed ...
6 December 2023 - As New Zealand’s response to the COVID-19 pandemic has evolved, so has ours. ...